AXIM Biotechnologies, Inc.

AXIM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
3 Jun 23, 2017 PRIMARY DOCUMENT
8-K Jun 16, 2017 FORM 8K CURRENT REPORT
10-Q May 22, 2017 FORM 10Q QUARTERLY REPORT
8-K May 17, 2017 FORM 8-K CURRENT REPORT
NT 10-Q May 16, 2017 FORM12B25 NOTICE OF LATE FILING
8-K May 15, 2017 FORM 8-K CURRENT REPORT
10-K/A Apr 19, 2017 FORM 10-K/A AMENDED ANNUAL REPORT
10-K Apr 17, 2017 FORM 10-K ANNUAL REPORT
NT 10-K Mar 31, 2017 FORM12B25 NOTICE OF LATE FILING
8-K Mar 28, 2017 FORM 8-K CURRENT REPORT
8-K Mar 22, 2017 FORM 8-K CURRENT REPORT
SC 13D/A Mar 1, 2017 SCHEDULE 13D/A1
SC 13D/A Mar 1, 2017 SCHEDULE 13D/A1
5/A Feb 28, 2017 PRIMARY DOCUMENT
5 Feb 15, 2017 PRIMARY DOCUMENT
5 Feb 15, 2017 PRIMARY DOCUMENT
5 Feb 15, 2017 PRIMARY DOCUMENT
8-K Jan 19, 2017 FORM 8-K CURRENT REPORT
8-K Jan 10, 2017 FORM 8-K CURRENT REPORT
8-K Dec 30, 2016 FORM 8-K CURRENT REPORT
8-K Dec 13, 2016 FORM 8-K CURRENT REPORT
10-Q/A Nov 30, 2016 FORM 10-Q/A AMENDED QUARTERLY REPORT
10-Q Nov 21, 2016 FORM 10-Q QUARTERLY REPORT
NT 10-Q Nov 14, 2016 FORM12B25 NOTICE OF LATE FILING
10-Q/A Aug 25, 2016 FORM 10-Q/A AMENDED QUARTERLY REPORT
← Newer Page 8 of 13 · 306 filings Older →